Moses Lake Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
JD & SN Inc. is recalling 92 testosterone pellets because the company cannot ensure they are sterile. The recall covers products distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in a compounded drug, which poses a risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling 92 units of Testosterone, Pellet, 100 mg. The recall was initiated because the company lacks assurance of the sterility of the product. The affected items are prescription-only compounded drugs.
The recall covers specific lots of the product distributed nationwide. The source text indicates that all sterile human compounded drugs within their expiry date are subject to this lack of assurance. The recall number is D-0125-2016.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for instructions on how to return or dispose of the medication.
The recalled product
- Product
- TESTOSTERONE, Pellet, 100 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 92
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- t12152014@14
- t12012014@1
- t11202014@24
- t10032014@18
- t09292014@8
- t09192014@15
- t09162014@8
- t07132015@13
- t06122015@2
- t05262015@11
- t05232014@5
- t04092015@14
- t03062015@26
- t03042015@17
- t02272015@21
- t02182015@31
- t02092015@24
- t01162015@14
- t01022015@15
- 11192014@8.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
Similar recalls
- HighQualgen Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- HighTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereQualgen Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-11-14
- SevereTestosterone Pellets Recalled for Potential Sterility Assurance Issues
FDA (Drugs) · 2015-09-23
- SevereTestosterone Sterile Pellets Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23